{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:34:35Z","timestamp":1790030075869,"version":"4.0.1"},"reference-count":207,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.autrev.2023.103340","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T11:54:45Z","timestamp":1681732485000},"page":"103340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["Insights into new-onset autoimmune diseases after COVID-19 vaccination"],"prefix":"10.1016","volume":"22","author":[{"given":"Ming","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinggang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2023.103340_bb0015","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41590-021-00900-w","volume":"22","author":"Coping with COVID","year":"2021","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2023.103340_bb0030","doi-asserted-by":"crossref","first-page":"2045853","DOI":"10.1080\/21645515.2022.2045853","article-title":"COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges","volume":"18","author":"Dhama","year":"2022","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.autrev.2023.103340_bb0035","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41586-021-03470-x","article-title":"Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England","volume":"593","author":"The COVID-19 Genomics UK (COG-UK) consortium","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2023.103340_bb0040","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41586-021-03402-9","article-title":"Detection of a SARS-CoV-2 variant of concern in South Africa","volume":"592","author":"Tegally","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2023.103340_bb0045","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1126\/science.abh2644","article-title":"Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil","volume":"372","author":"Faria","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.autrev.2023.103340_bb0050","doi-asserted-by":"crossref","first-page":"537","DOI":"10.4103\/ijmr.ijmr_1353_21","article-title":"A focus on the spread of the delta variant of SARS-CoV-2 in India","volume":"153","author":"Novelli","year":"2021","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.autrev.2023.103340_bb0055","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/jmv.27491","article-title":"Omicron variant (B.1.1.529) of SARS-CoV-2, a global urgent public health alert!","volume":"94","author":"Gao","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.autrev.2023.103340_bb0060","doi-asserted-by":"crossref","first-page":"biaa133","DOI":"10.1093\/biosci\/biaa133","article-title":"Will a COVID vaccine be accepted?","author":"Tibbetts","year":"2020","journal-title":"BioScience"},{"key":"10.1016\/j.autrev.2023.103340_bb0065","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000523962","article-title":"New Onset Biopsy-Proven Nephropathies after COVID Vaccination","volume":"53","author":"Fenoglio","year":"2022","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.autrev.2023.103340_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109061","article-title":"Autoimmune inflammatory rheumatic diseases post-COVID-19 vaccination","volume":"110","author":"Safary","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2023.103340_bb0075","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jhep.2021.06.004","article-title":"Another case of autoimmune hepatitis after SARS-CoV-2 vaccination \u2013 still casualty?","volume":"75","author":"Londo\u00f1o","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0080","series-title":"Vaccines and Autoimmunity","author":"Martino","year":"2013"},{"key":"10.1016\/j.autrev.2023.103340_bb0085","doi-asserted-by":"crossref","first-page":"16001","DOI":"10.1038\/nrdp.2016.1","article-title":"IgA nephropathy","volume":"2","author":"Lai","year":"2016","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.autrev.2023.103340_bb0090","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1016\/j.vaccine.2022.03.003","article-title":"IgA nephropathy in a pediatric patient after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine","volume":"40","author":"Abdel-Qader","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.autrev.2023.103340_bb0095","doi-asserted-by":"crossref","first-page":"395","DOI":"10.31486\/toj.21.0083","article-title":"De Novo immunoglobulin A vasculitis following exposure to SARS-CoV-2 immunization","volume":"21","author":"Mohamed","year":"2021","journal-title":"Ochsner J"},{"key":"10.1016\/j.autrev.2023.103340_bb0100","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00467-021-05351-x","article-title":"IgA nephropathy presenting as rapidly progressive glomerulonephritis following first dose of COVID-19 vaccine","volume":"37","author":"Niel","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.autrev.2023.103340_bb0105","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s13730-021-00679-7","article-title":"An adolescent girl diagnosed with IgA nephropathy following the first dose of the COVID-19 vaccine","volume":"11","author":"Okada","year":"2022","journal-title":"CEN Case Rep"},{"key":"10.1016\/j.autrev.2023.103340_bb0110","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s13730-021-00670-2","article-title":"Abrupt worsening of occult IgA nephropathy after the first dose of SARS-CoV-2 vaccination","volume":"11","author":"Fujita","year":"2022","journal-title":"CEN Case Rep"},{"key":"10.1016\/j.autrev.2023.103340_bb0115","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s13730-022-00707-0","article-title":"IgA nephropathy with glomerular capillary IgA deposition following SARS-CoV-2 mRNA vaccination: a report of three cases","volume":"11","author":"Yokote","year":"2022","journal-title":"CEN Case Rep"},{"key":"10.1016\/j.autrev.2023.103340_bb0120","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.kint.2021.05.016","article-title":"De novo vasculitis after mRNA-1273 (Moderna) vaccination","volume":"100","author":"Anderegg","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2023.103340_bb0125","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1016\/j.ekir.2021.09.008","article-title":"COVID-19 vaccination and glomerulonephritis","volume":"6","author":"Klomjit","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.autrev.2023.103340_bb0130","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/nep.13992","article-title":"Gross haematuria after mRNA COVID -19 vaccination in two patients with histological and clinical diagnosis of IgA nephropathy","volume":"27","author":"Lo","year":"2022","journal-title":"Nephrology"},{"key":"10.1016\/j.autrev.2023.103340_bb0135","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.kint.2021.06.032","article-title":"IgA nephropathy presenting as macroscopic hematuria in 2 pediatric patients after receiving the Pfizer COVID-19 vaccine","volume":"100","author":"Hanna","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2023.103340_bb0140","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2169\/internalmedicine.8787-21","article-title":"IgA nephropathy with gross hematuria following COVID-19 mRNA vaccination","volume":"61","author":"Nihei","year":"2022","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2023.103340_bb0145","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.xkme.2021.05.002","article-title":"IgA nephropathy after SARS-CoV-2 vaccination","volume":"3","author":"Abramson","year":"2021","journal-title":"Kidney Med"},{"key":"10.1016\/j.autrev.2023.103340_bb0150","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1016\/j.ekir.2021.06.007","article-title":"Letter regarding: \u201cA Case of Gross Hematuria and IgA Nephropathy Flare-Up Following SARS-CoV-2 Vaccination.\u201d","volume":"6","author":"Park","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.autrev.2023.103340_bb0155","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3390\/vaccines10020302","article-title":"New-onset kidney diseases after COVID-19 vaccination: a case series","volume":"10","author":"Lim","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.autrev.2023.103340_bb0160","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.kint.2021.06.011","article-title":"Histologic correlates of gross hematuria following Moderna COVID-19 vaccine in patients with IgA nephropathy","volume":"100","author":"Kudose","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2023.103340_bb0165","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/qjmed\/hcab305","article-title":"Newly diagnosed IgA nephropathy with gross haematuria following COVID-19 vaccination","volume":"115","author":"Horino","year":"2022","journal-title":"QJM Int J Med"},{"key":"10.1016\/j.autrev.2023.103340_bb0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5414\/CN110689","article-title":"Need for symptom monitoring in IgA nephropathy patients post COVID-19 vaccination","volume":"97","author":"Srinivasan","year":"2022","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.autrev.2023.103340_bb0175","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00467-022-05518-0","article-title":"Two patients presenting IgA nephropathy after COVID-19 vaccination during a follow-up for asymptomatic hematuria","volume":"37","author":"Morisawa","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.autrev.2023.103340_bb0180","article-title":"IgA de novo en trasplante renal tras vacunaci\u00f3n frente a SARS-CoV-2","author":"Alonso","year":"2021","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.autrev.2023.103340_bb0185","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/1744-9987.13765","article-title":"IgA nephropathy following SARS-CoV -2 vaccination in a renal transplant recipient with a history of aristolochic acid nephropathy","volume":"26","author":"Mokos","year":"2022","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.autrev.2023.103340_bb0190","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000523962","article-title":"New onset biopsy-proven nephropathies after COVID vaccination","volume":"53","author":"Fenoglio","year":"2022","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.autrev.2023.103340_bb0195","doi-asserted-by":"crossref","DOI":"10.1177\/03000605221129674","article-title":"Newly-diagnosed immunoglobulin A nephropathy with increased plasma galactose-deficient-IgA 1 antibody associated with mRNA COVID-19 vaccination: a case report","volume":"50","author":"Chen","year":"2022","journal-title":"J Int Med Res"},{"key":"10.1016\/j.autrev.2023.103340_bb0200","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000030066","article-title":"New-onset crescent IgA nephropathy following the CoronaVac vaccine: A case report","volume":"101","author":"Ran","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2023.103340_bb0205","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s13730-021-00677-9","article-title":"New-onset kidney biopsy-proven IgA vasculitis after receiving mRNA-1273 COVID-19 vaccine: case report","volume":"11","author":"Nakatani","year":"2022","journal-title":"CEN Case Rep"},{"key":"10.1016\/j.autrev.2023.103340_bb0210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-021-00303-z","article-title":"Membranous nephropathy","volume":"7","author":"Ronco","year":"2021","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.autrev.2023.103340_bb0215","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.34067\/KID.0005372021","article-title":"Glomerular Disease in Temporal Association with SARS-CoV-2 Vaccination: A Series of 29 Cases","volume":"2","author":"Caza","year":"2021","journal-title":"Kidney360"},{"key":"10.1016\/j.autrev.2023.103340_bb0220","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/vaccines11010080","article-title":"Membranous nephropathy following full-dose of inactivated SARS-CoV-2 virus vaccination: a case report and literature review","volume":"11","author":"Thammathiwat","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.autrev.2023.103340_bb0225","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.kint.2021.07.016","article-title":"A case of membranous nephropathy following Pfizer\u2013BioNTech mRNA vaccination against COVID-19","volume":"100","author":"Da","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2023.103340_bb0230","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.kint.2021.08.006","article-title":"Membranous nephropathy following anti\u2013COVID-19 mRNA vaccination","volume":"100","author":"Gueguen","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2023.103340_bb0235","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.24245","article-title":"A case of membranous nephropathy hypothesized to be associated with COVID-19 vaccine","author":"Rashid","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.autrev.2023.103340_bb0240","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ckj\/sfab252","article-title":"Two cases of glomerular involvement after vaccination against COVID-19: epiphenomenon or causality?","volume":"15","author":"Psyllaki","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.autrev.2023.103340_bb0245","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1111\/ajt.17166","article-title":"De novo posttransplant membranous nephropathy following BNT162b2 mRNA COVID-19 vaccine in a kidney transplant recipient","volume":"22","author":"Chavarot","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.autrev.2023.103340_bb0250","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/imj.15915","article-title":"De novo PLA2R positive membranous nephropathy following BNT162b2 mRNA COVID-19 vaccine","volume":"52","author":"Paxton","year":"2022","journal-title":"Intern Med J"},{"key":"10.1016\/j.autrev.2023.103340_bb0255","doi-asserted-by":"crossref","first-page":"S377","DOI":"10.1016\/j.ekir.2022.01.910","article-title":"POS-872 Post covid vaccination- new onset glomerulonephritis- a mere co incidence or a impending reality??","volume":"7","author":"Saigal","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.autrev.2023.103340_bb0260","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfac067.007","article-title":"De novo glomerulonephritides following bnt162b2 covid-19 vaccine: a case series","author":"Fornara","year":"2022","journal-title":"Nephrol. Dialysis Transplant."},{"key":"10.1016\/j.autrev.2023.103340_bb0265","doi-asserted-by":"crossref","first-page":"S389","DOI":"10.1016\/j.ekir.2022.01.936","article-title":"POS-897 a case of de novo nell-1 membranous nephropathy post covid-19 vaccination","volume":"7","author":"Garg","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.autrev.2023.103340_bb0270","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41541-021-00336-1","article-title":"Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2","volume":"6","author":"McDonald","year":"2021","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.autrev.2023.103340_bb0275","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMc1011678","article-title":"PLA 2 R autoantibodies and PLA 2 R glomerular deposits in membranous nephropathy","volume":"364","author":"Debiec","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2023.103340_bb0280","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.autrev.2023.103340_bb0285","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1111\/jocd.14386","article-title":"Systemic lupus erythematosus after COVID-19 vaccination: A case report","volume":"20","author":"Patil","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0290","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/qjmed\/hcab229","article-title":"The Emergence of new-onset SLE following SARS-CoV-2 vaccination","volume":"114","author":"Nune","year":"2021","journal-title":"QJM Int J Med"},{"key":"10.1016\/j.autrev.2023.103340_bb0295","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12185-021-03243-2","article-title":"New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination","volume":"115","author":"Hidaka","year":"2022","journal-title":"Int J Hematol"},{"key":"10.1016\/j.autrev.2023.103340_bb0300","first-page":"35","article-title":"New-onset systemic lupus erythematosus after ChAdOX1 nCoV-19 and alopecia areata after BNT162b2 vaccination against SARS-CoV-2","author":"Gamonal","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.autrev.2023.103340_bb0305","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/mrcr\/rxac018","article-title":"Systemic lupus erythematosus and antiphospholipid syndrome after COVID-19 vaccination. A case report","volume":"7","author":"Molina-Rios","year":"2023","journal-title":"Mod Rheumatol Case Rep"},{"key":"10.1016\/j.autrev.2023.103340_bb0310","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/kjm2.12630","article-title":"Systemic lupus erythematosus with acrocyanosis after AstraZeneca COVID -19 vaccination","volume":"38","author":"Wang","year":"2022","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.autrev.2023.103340_bb0315","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s10067-022-06097-z","article-title":"Systemic lupus erythematosus with acute pancreatitis and vasculitic rash following COVID-19 vaccine: a case report and literature review","volume":"41","author":"Alrashdi Mousa","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0320","article-title":"First presentation of systemic lupus erythematosus in a 24-year-old male following mRNA COVID-19 vaccine","author":"Raviv","year":"2022","journal-title":"Case Rep Rheumatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0325","first-page":"1","article-title":"New-onset systemic lupus erythematosus after mRNA SARS-CoV-2 vaccination","volume":"2022","author":"B\u00e1ez-Negr\u00f3n","year":"2022","journal-title":"Case Rep Rheumatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0330","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s10067-022-06126-x","article-title":"Systemic lupus erythematous after Pfizer COVID-19 vaccine: a case report","volume":"41","author":"Lemoine","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0335","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jdcr.2022.09.026","article-title":"New diagnosis of systemic lupus erythematosus after COVID-19 vaccination: A case report and review of literature","volume":"30","author":"Khanna","year":"2022","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.autrev.2023.103340_bb0340","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1002\/jmv.28092","article-title":"Autoimmune rheumatic disease after SARS-CoV-2 vaccination","volume":"94","author":"Ghang","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.autrev.2023.103340_bb0345","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/cmi.2017.151","article-title":"Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction","volume":"15","author":"Segal","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.autrev.2023.103340_bb0350","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","article-title":"COVID-19 vaccines: modes of immune activation and future challenges","volume":"21","author":"Teijaro","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2023.103340_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2015.08.003","article-title":"Vaccines, adjuvants and autoimmunity","author":"Guimar\u00e3es","year":"2015","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.autrev.2023.103340_bb0360","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1177\/0961203309345732","article-title":"Ten cases of systemic lupus erythematosus related to hepatitis B vaccine","volume":"18","author":"Agmon-Levin","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2023.103340_bb0365","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12026-016-8815-9","article-title":"Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case\u2013control assessment of the vaccine adverse event reporting system (VAERS) database","volume":"65","author":"Geier","year":"2017","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2023.103340_bb0370","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.kint.2021.09.009","article-title":"New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination","volume":"100","author":"Zavala-Miranda","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2023.103340_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2022.01.013","article-title":"New-onset class III lupus nephritis with multi-organ involvement after COVID-19 vaccination","author":"Kim","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2023.103340_bb0380","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s41927-022-00313-8","article-title":"Presentation of SLE after COVID vaccination in a pediatric patient","volume":"6","author":"Nelson","year":"2022","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0385","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2215\/CJN.05960616","article-title":"Focal segmental glomerulosclerosis","volume":"12","author":"Rosenberg","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2023.103340_bb0390","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4103\/ijn.ijn_23_22","article-title":"Post covishield (ChAdOx1 nCoV-19) vaccination: New onset focal segmental glomerulosclerosis resistant to steroid and calcineurin inhibitor","volume":"32","author":"Jha","year":"2022","journal-title":"Indian J Nephrol"},{"key":"10.1016\/j.autrev.2023.103340_bb0395","doi-asserted-by":"crossref","DOI":"10.3238\/arztebl.m2021.0330","article-title":"Nephrotic syndrome after vaccination against COVID-19: three new cases from Germany","author":"Dormann","year":"2021","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"10.1016\/j.autrev.2023.103340_bb0400","doi-asserted-by":"crossref","first-page":"263","DOI":"10.23876\/j.krcp.21.308","article-title":"Focal segmental glomerulosclerosis following the Pfizer-BioNTech COVID-19 vaccine","volume":"41","author":"Lim","year":"2022","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.autrev.2023.103340_bb0405","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfac067.029","article-title":"De novo double glomerulopathy (membranous nephropathy, MN and collapsing focal segmental glomerulosclerosis, cfsgs) associated to positive myeloperoxidase-o (mpo) antibody following pfizer \u2013 biontech mrna vaccination covid 19","author":"Marega","year":"2022","journal-title":"Nephrol. Dialysis Transplant."},{"key":"10.1016\/j.autrev.2023.103340_bb0410","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2023.103340_bb0415","article-title":"A case report of MPO-ANCA-associated vasculitis following heterologous mRNA1273 COVID-19 booster vaccination","volume":"37","author":"Kim","year":"2022","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.autrev.2023.103340_bb0420","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3390\/pathogens10081045","article-title":"Renal thrombotic microangiopathy in concurrent COVID-19 vaccination and infection","volume":"10","author":"De Fabritiis","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.autrev.2023.103340_bb0425","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00467-017-3783-4","article-title":"Influenza-associated thrombotic microangiopathies","volume":"33","author":"Bitzan","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.autrev.2023.103340_bb0430","doi-asserted-by":"crossref","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.autrev.2023.103340_bb0435","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.2169\/internalmedicine.0257-22","article-title":"New-onset seropositive rheumatoid arthritis following COVID-19 vaccination in a patient with seronegative status","volume":"61","author":"Yonezawa","year":"2022","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2023.103340_bb0440","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.29660","article-title":"A case series on the COVID-19 vaccines and possible immune-related adverse events: a new challenge for the rheumatologists","author":"Nahra","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.autrev.2023.103340_bb0445","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000030806","article-title":"BNT162b2 coronavirus disease-2019 vaccination accelerated rheumatoid arthritis disease activity in chronic eosinophilic pneumonia: A case report","volume":"101","author":"Morikawa","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2023.103340_bb0450","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/1756-185X.14220","article-title":"Seropositive rheumatoid arthritis after vaccination against SARS-CoV-2 infection","volume":"24","author":"Baimukhamedov","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103340_bb0455","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.859926","article-title":"Case report: new-onset rheumatoid arthritis following COVID-19 vaccination","volume":"13","author":"Watanabe","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103340_bb0460","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60709-X","article-title":"Antiphospholipid syndrome","volume":"376","author":"Ruiz-Irastorza","year":"2010","journal-title":"The Lancet"},{"key":"10.1016\/j.autrev.2023.103340_bb0465","doi-asserted-by":"crossref","DOI":"10.55563\/clinexprheumatol\/s3sbgu","article-title":"Catastrophic antiphospholipid syndrome triggered by mRNA COVID-19 vaccine","author":"Moreno-Torres","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0470","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/mrcr\/rxac018","article-title":"Systemic lupus erythematosus and antiphospholipid syndrome after COVID-19 vaccination. A case report","volume":"7","author":"Molina-Rios","year":"2023","journal-title":"Mod Rheumatol Case Rep"},{"key":"10.1016\/j.autrev.2023.103340_bb0475","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s40265-018-0956-9","article-title":"Adult-onset still\u2019s disease: molecular pathophysiology and therapeutic advances","volume":"78","author":"Sfriso","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.autrev.2023.103340_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108878","article-title":"Adult-onset still\u2019s disease following mRNA COVID-19 vaccination","volume":"233","author":"Sharabi","year":"2021","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2023.103340_bb0485","doi-asserted-by":"crossref","first-page":"333","DOI":"10.12688\/wellcomeopenres.17345.2","article-title":"Case report: adult onset still\u2019s disease after vaccination against Covid-19","volume":"6","author":"Risal","year":"2022","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.autrev.2023.103340_bb0490","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2169\/internalmedicine.0590-22","article-title":"New-onset adult-onset still\u2019s disease following COVID-19 vaccination: three case reports and a literature review","volume":"62","author":"Matsuda","year":"2023","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2023.103340_bb0495","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2021.36.e344","article-title":"Adult-onset still\u2019s disease after BNT162b2 mRNA COVID-19 vaccine","volume":"36","author":"Park","year":"2021","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.autrev.2023.103340_bb0500","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3899\/jrheum.220219","article-title":"Adult-onset still disease after ChAdOx1 nCOV-19 vaccination","volume":"50","author":"Weng","year":"2023","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0505","doi-asserted-by":"crossref","DOI":"10.55563\/clinexprheumatol\/vx44zn","article-title":"New onset and flare of rheumatic diseases following COVID-19 vaccination are mild and respond well to treatment: 9-month follow-up data from a single centre cohort","author":"Gasparotto","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0510","article-title":"Adult-onset Still\u2019s disease after ChAdOx1 nCoV-19 vaccine: a possible association","volume":"12","author":"Albertino","year":"2022","journal-title":"Autopsy Case Rep"},{"key":"10.1016\/j.autrev.2023.103340_bb0515","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1111\/imj.15563","article-title":"Adult-onset Still disease post-adenovirus vector COVID -19 vaccine","volume":"51","author":"Sweeney","year":"2021","journal-title":"Intern Med J"},{"key":"10.1016\/j.autrev.2023.103340_bb0520","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s10067-022-06065-7","article-title":"New-onset Adult-onset Still\u2019s disease-like syndrome after ChAdOx1 nCoV-19 vaccination\u2014a case series with review of literature","volume":"41","author":"Padiyar","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0525","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3390\/vaccines10071022","article-title":"Adult-onset still\u2019s disease-like syndrome following COVID-19 vaccination: a case report and review of the literature","volume":"10","author":"Winichakoon","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.autrev.2023.103340_bb0530","doi-asserted-by":"crossref","first-page":"e678","DOI":"10.1016\/S2665-9913(21)00218-6","article-title":"Adult-onset Still\u2019s disease following COVID-19 vaccination","volume":"3","author":"Leone","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0535","doi-asserted-by":"crossref","first-page":"e680","DOI":"10.1016\/S2665-9913(21)00219-8","article-title":"Adult-onset Still\u2019s disease after mRNA COVID-19 vaccine","volume":"3","author":"Magliulo","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0540","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.21279","article-title":"Adult-onset Still\u2019s disease after the ChAdOx1 nCoV-19 vaccine","author":"AlQudari","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.autrev.2023.103340_bb0545","first-page":"3","article-title":"Hyper-inflammation after COVID-19 mARN vaccination: at the crossroads of multisystem inflammatory disease and adult-onset Still\u2019s disease. Does terminology matter?","volume":"60","author":"Baicus","year":"2022","journal-title":"Rom J Intern Med"},{"key":"10.1016\/j.autrev.2023.103340_bb0550","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3390\/vaccines10101687","article-title":"Adult-onset Still\u2019s disease following coronavirus 2 (SARS-CoV-2) vaccination: a case report","volume":"10","author":"Chua","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.autrev.2023.103340_bb0555","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching","year":"2020","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.autrev.2023.103340_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.amsu.2022.104123","article-title":"ANCA-associated vasculitis following Johnson and Johnson COVID-19 vaccine","volume":"79","author":"Yadav","year":"2022","journal-title":"Ann Med Surg"},{"key":"10.1016\/j.autrev.2023.103340_bb0565","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.2169\/internalmedicine.9807-22","article-title":"Antineutrophil cytoplasmic antibody-associated vasculitis after COVID-19 vaccination with Pfizer-BioNTech","volume":"61","author":"Suzuki","year":"2022","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2023.103340_bb0570","article-title":"A case report of MPO-ANCA-associated vasculitis following heterologous mRNA1273 COVID-19 booster vaccination","volume":"37","author":"Kim","year":"2022","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.autrev.2023.103340_bb0575","series-title":"A Case of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis Post COVID-19 Vaccination","author":"Al-Yafeai","year":"2022"},{"key":"10.1016\/j.autrev.2023.103340_bb0580","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.30206","article-title":"Antineutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis following COVID-19 VACCINATION: A CASE REPORT AND LITERATURE REVIEW","author":"Uddin","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.autrev.2023.103340_bb0585","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1053\/j.ajkd.2021.06.016","article-title":"ANCA-associated vasculitis following Pfizer-BioNTech COVID-19 vaccine","volume":"78","author":"Shakoor","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2023.103340_bb0590","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.kint.2021.05.017","article-title":"ANCA glomerulonephritis after the moderna COVID-19 vaccination","volume":"100","author":"Sekar","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2023.103340_bb0595","doi-asserted-by":"crossref","DOI":"10.1177\/20406223221125708","article-title":"ANCA-associated vasculitis following the CoronaVac vaccination","volume":"13","author":"Ma","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.autrev.2023.103340_bb0600","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.kint.2021.07.026","article-title":"A case of ANCA-associated vasculitis after AZD1222 (Oxford\u2013AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?","volume":"100","author":"Villa","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2023.103340_bb0605","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3390\/life12071072","article-title":"ANCA-associated vasculitis may result as a complication to both SARS-CoV-2 infection and vaccination","volume":"12","author":"Christodoulou","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.autrev.2023.103340_bb0610","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00296-021-05069-x","article-title":"ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review","volume":"42","author":"Prabhahar","year":"2022","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2023.103340_bb0615","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3390\/vaccines10050653","article-title":"Dual-positive MPO- and PR3-ANCA-associated vasculitis following SARS-CoV-2 mRNA booster vaccination: a case report and systematic review","volume":"10","author":"Baier","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.autrev.2023.103340_bb0620","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/ckj\/sfab181","article-title":"MPO-ANCA-associated vasculitis after the Pfizer\/BioNTech SARS-CoV-2 vaccination","volume":"15","author":"Obata","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.autrev.2023.103340_bb0625","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.19616","article-title":"De-novo antineutrophil cytoplasmic antibody-associated vasculitis following the mRNA-1273 (Moderna) vaccine for COVID-19","author":"Feghali","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.autrev.2023.103340_bb0630","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1016\/j.ekir.2021.08.012","article-title":"Antineutrophil cytoplasmic autoantibody\u2013associated glomerulonephritis following the Pfizer-BioNTech COVID-19 vaccine","volume":"6","author":"Dube","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.autrev.2023.103340_bb0635","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/qjmed\/hcab227","article-title":"Myeloperoxidase anti-neutrophil cytoplasmic antibody positive optic perineuritis after mRNA coronavirus disease-19 vaccine","volume":"114","author":"Takenaka","year":"2021","journal-title":"QJM Int J Med"},{"key":"10.1016\/j.autrev.2023.103340_bb0640","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.kint.2021.05.016","article-title":"De novo vasculitis after mRNA-1273 (Moderna) vaccination","volume":"100","author":"Anderegg","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2023.103340_bb0645","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2022.37.e154","article-title":"Microscopic polyangiitis following mRNA COVID-19 vaccination: a case report","volume":"37","author":"So","year":"2022","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.autrev.2023.103340_bb0650","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l1964","article-title":"Giant cell arteritis","author":"Lazarewicz","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.autrev.2023.103340_bb0655","doi-asserted-by":"crossref","first-page":"105282","DOI":"10.1016\/j.jbspin.2021.105282","article-title":"SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: \u201cCan SARS-CoV-2 trigger relapse of polymyalgia rheumatica?\u201d by Manzo et al. Joint Bone Spine 2021;88:105150","volume":"89","author":"Cadiou","year":"2022","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2023.103340_bb0660","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.210724","article-title":"Case of giant cell arteritis after SARS-CoV-2 vaccination: a particular phenotype?","volume":"49","author":"Sauret","year":"2022","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0665","first-page":"186","article-title":"Bilateral giant cell arteritis with skin necrosis following SARS-CoV-2 vaccination","author":"Gambichler","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0670","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/03009742.2021.1961401","article-title":"Large-vessel giant cell arteritis after COVID-19 vaccine","volume":"51","author":"Mejren","year":"2022","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0675","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s10067-021-06041-7","article-title":"New-onset giant cell arteritis following COVID-19 mRNA (BioNTech\/Pfizer) vaccine: a double-edged sword?","volume":"41","author":"Anzola","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0680","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/03009742.2021.1995985","article-title":"COVID-19 vaccination and large-vessel giant cell arteritis","volume":"51","author":"Mungmungpuntipantip","year":"2022","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0685","doi-asserted-by":"crossref","first-page":"228","DOI":"10.55563\/clinexprheumatol\/u1v6z1","article-title":"COVID-19 vaccination unveiling subclinical Sj\u00f6gren\u2019s syndrome","volume":"39","author":"Ramos-Casals","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0690","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1093\/rheumatology\/keab751","article-title":"Beh\u00e7et\u2019s-like adverse event or inaugural Beh\u00e7et\u2019s disease after SARS-CoV-2 mRNA-1273 vaccination?","volume":"61","author":"Tagini","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2023.103340_bb0695","doi-asserted-by":"crossref","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","article-title":"Autoimmune hepatitis","volume":"4","author":"Mieli-Vergani","year":"2018","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.autrev.2023.103340_bb0700","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jhep.2021.04.003","article-title":"Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?","volume":"75","author":"Bril","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0705","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000440747","article-title":"Role of histopathology in autoimmune hepatitis","volume":"33","author":"Tiniakos","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.autrev.2023.103340_bb0710","article-title":"Features and outcome of AIH patients without elevation of IgG","volume":"2","author":"Hartl","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.autrev.2023.103340_bb0715","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jhep.2021.05.038","article-title":"Autoimmune hepatitis following SARS-CoV-2 vaccine: May not be a casuality","volume":"75","author":"Rocco","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0720","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/liv.15092","article-title":"A typical autoimmune hepatitis (AIH) case following Covid-19 mRNA vaccination. More than a coincidence?","volume":"42","author":"Goulas","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.autrev.2023.103340_bb0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102706","article-title":"Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?","volume":"123","author":"Ghielmetti","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2023.103340_bb0730","doi-asserted-by":"crossref","first-page":"goac014","DOI":"10.1093\/gastro\/goac014","article-title":"Acute hepatitis with autoimmune features after COVID-19 vaccine: coincidence or vaccine-induced phenomenon?","volume":"10","author":"Pinazo-Bandera","year":"2022","journal-title":"Gastroenterol Rep"},{"key":"10.1016\/j.autrev.2023.103340_bb0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102688","article-title":"Auto-immune hepatitis following COVID vaccination","volume":"123","author":"Rela","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2023.103340_bb0740","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1111\/liv.15350","article-title":"Autoimmune hepatitis (AIH) following coronavirus (COVID -19) vaccine\u2014No longer exclusive to mRNA vaccine?","volume":"42","author":"Shahrani","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.autrev.2023.103340_bb0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102741","article-title":"Autoimmune hepatitis after COVID-19 vaccine \u2013 more than a coincidence","volume":"125","author":"Garrido","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2023.103340_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102745","article-title":"Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up?","volume":"125","author":"Avci","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2023.103340_bb0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101841","article-title":"Autoimmune hepatitis developing after COVID 19 vaccine: Presumed guilty?","volume":"46","author":"Erard","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103340_bb0760","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2021.06.014","article-title":"Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine","volume":"75","author":"Clayton-Chubb","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102874","article-title":"Autoimmune hepatitis following COVID-19 vaccination","volume":"132","author":"Izagirre","year":"2022","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2023.103340_bb0770","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jhep.2021.06.009","article-title":"Autoimmune hepatitis following COVID-19 vaccination: True causality or mere association?","volume":"75","author":"Tan","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0775","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2022.37.e116","article-title":"Autoimmune hepatitis following vaccination for SARS-Cov-2 in Korea: coincidence or autoimmunity?","volume":"37","author":"Kang","year":"2022","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.autrev.2023.103340_bb0780","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/liv.15224","article-title":"Autoimmune hepatitis or drug-induced autoimmune hepatitis following Covid-19 vaccination?","volume":"42","author":"Fimiano","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.autrev.2023.103340_bb0785","doi-asserted-by":"crossref","DOI":"10.14309\/crj.0000000000000811","article-title":"Autoimmune hepatitis triggered by COVID-19 vaccine: the first case from inactivated vaccine","volume":"9","author":"Mekritthikrai","year":"2022","journal-title":"ACG Case Rep J"},{"key":"10.1016\/j.autrev.2023.103340_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102710","article-title":"Autoimmune hepatitis triggered by SARS-CoV-2 vaccination","volume":"123","author":"Vuille-Lessard","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2023.103340_bb0795","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s12328-022-01654-0","article-title":"Autoimmune hepatitis with history of HCV treatment triggered by COVID-19 vaccination: case report and literature review","volume":"15","author":"Hasegawa","year":"2022","journal-title":"Clin J Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103340_bb0800","article-title":"COVID-19 vaccine and autoimmunity. A new case of autoimmune hepatitis and review of the literature","volume":"5","author":"Camacho-Dom\u00ednguez","year":"2022","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.autrev.2023.103340_bb0805","article-title":"COVID-19 vaccine triggered autoimmune hepatitis: case report. Eur","author":"Mathew","year":"2022","journal-title":"J Hosp Pharm"},{"key":"10.1016\/j.autrev.2023.103340_bb0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijscr.2022.106926","article-title":"Drug-induced hepatitis after Sinopharm COVID-19 vaccination: A case study of a 62-year-old patient","volume":"93","author":"Ghorbani","year":"2022","journal-title":"Int J Surg Case Rep"},{"key":"10.1016\/j.autrev.2023.103340_bb0815","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jhep.2021.09.031","article-title":"Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed","volume":"76","author":"Zin Tun","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0820","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/hep.32156","article-title":"Letter to the editor: Autoimmune hepatitis after COVID-19 vaccination: A rare adverse effect?","volume":"75","author":"Palla","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2023.103340_bb0825","article-title":"Liver injury with autoimmune features after vaccination against SARS-CoV-2: The verdict is still open","author":"Ferronato","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.autrev.2023.103340_bb0830","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jhep.2021.08.006","article-title":"New-onset autoimmune hepatitis following mRNA COVID-19 vaccination in a 36-year-old woman with primary sclerosing cholangitis \u2013 should we be more vigilant?","volume":"76","author":"Zhou","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0835","doi-asserted-by":"crossref","DOI":"10.17235\/reed.2022.8820\/2022","article-title":"SARS-CoV-2 vaccine, a new autoimmune hepatitis trigger?","author":"L\u00f3pez Romero-Salazar","year":"2022","journal-title":"Rev Esp Enfermedades Dig"},{"key":"10.1016\/j.autrev.2023.103340_bb0840","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.jhep.2021.06.044","article-title":"The mRNA COVID-19 vaccine \u2013 A rare trigger of autoimmune hepatitis?","volume":"75","author":"McShane","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"Vojdani","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2023.103340_bb0850","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/j.clinre.2019.02.007","article-title":"Development of autoimmune hepatitis after influenza vaccination; trigger or killer?","volume":"43","author":"Muratori","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103340_bb0855","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines \u2014 a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.autrev.2023.103340_bb0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108665","article-title":"Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to \u201cpotential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases\u201d","volume":"224","author":"Talotta","year":"2021","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2023.103340_bb0865","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","article-title":"COVID-19 vaccines: modes of immune activation and future challenges","volume":"21","author":"Teijaro","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2023.103340_bb0870","doi-asserted-by":"crossref","DOI":"10.7326\/AITC202203150","article-title":"Type 1 Diabetes Mellitus","volume":"175","author":"Syed","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2023.103340_bb0875","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102738","article-title":"A case of Graves\u2019 disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination","volume":"125","author":"Patrizio","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2023.103340_bb0880","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2022.101324","article-title":"Fulminant type 1 diabetes after COVID-19 vaccination","volume":"48","author":"Tang","year":"2022","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.autrev.2023.103340_bb0885","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3201\/eid2807.220127","article-title":"Type 1 diabetes mellitus associated with nivolumab after second SARS-CoV-2 vaccination","volume":"28","author":"Sato","year":"2022","journal-title":"Japan. Emerg Infect Dis"},{"key":"10.1016\/j.autrev.2023.103340_bb0890","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2169\/internalmedicine.9004-21","article-title":"New-onset Type 1 diabetes after COVID-19 mRNA vaccination","volume":"61","author":"Yano","year":"2022","journal-title":"Intern Med"},{"key":"10.1016\/j.autrev.2023.103340_bb0895","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2023.38.e12","article-title":"Adult-onset Type 1 diabetes development following COVID-19 mRNA vaccination","volume":"38","author":"Moon","year":"2023","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.autrev.2023.103340_bb0900","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/jdi.13781","article-title":"Type 1 diabetes mellitus following COVID-19 RNA-based vaccine","volume":"13","author":"Sakurai","year":"2022","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.autrev.2023.103340_bb0905","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/jdi.13757","article-title":"Newly developed type 1 diabetes after coronavirus disease 2019 vaccination: A case report","volume":"13","author":"Sasaki","year":"2022","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.autrev.2023.103340_bb0910","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12020-022-03130-8","article-title":"Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination","volume":"78","author":"Aydo\u011fan","year":"2022","journal-title":"Endocrine"},{"key":"10.1016\/j.autrev.2023.103340_bb0915","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s40618-022-01796-5","article-title":"COVID-19 vaccine and autoimmune diabetes in adults: report of two cases","volume":"45","author":"Bleve","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.autrev.2023.103340_bb0920","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJMcp1900554","article-title":"Warm autoimmune hemolytic anemia","volume":"381","author":"Brodsky","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2023.103340_bb0925","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1515\/cclm-2022-0118","article-title":"Life-threatening autoimmune hemolytic anemia following mRNA COVID-19 vaccination: don\u2019t be too prudent with the red gold","volume":"60","author":"De Bruyne","year":"2022","journal-title":"Clin Chem Lab Med CCLM"},{"key":"10.1016\/j.autrev.2023.103340_bb0930","first-page":"1","article-title":"A Case of autoimmune hemolytic anemia after the first dose of COVID-19 mRNA-1273 vaccine with undetected pernicious anemia","volume":"2022","author":"Jaydev","year":"2022","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.autrev.2023.103340_bb0935","article-title":"Autoimmune hemolytic anemia after mRNA COVID Vaccine","volume":"10","author":"Fatima","year":"2022","journal-title":"J Investig Med High Impact Case Rep"},{"key":"10.1016\/j.autrev.2023.103340_bb0940","first-page":"44","article-title":"A case of severe autoimmune hemolytic anemia after a receipt of a first dose of SARS-CoV-2 vaccine","author":"Murdych","year":"2022","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.autrev.2023.103340_bb0945","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1111\/trf.16672","article-title":"Severe autoimmune hemolytic anemia following receipt of SARS-CoV -2 mRNA vaccine","volume":"61","author":"Gadi","year":"2021","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.autrev.2023.103340_bb0950","first-page":"802","article-title":"Severe autoimmune haemolytic anaemia following SARS-CoV-2 vaccination in patients with treatment na\u00efve B-cell neoplasms: a case series","volume":"54","author":"Abasszade","year":"2022","journal-title":"Pathology (Phila)"},{"key":"10.1016\/j.autrev.2023.103340_bb0955","first-page":"190","article-title":"Is molecular mimicry the culprit in the autoimmune haemolytic anaemia affecting patients with COVID-19?","author":"Angileri","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2023.103340_bb0960","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2023.103340_bb0965","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/S0735-1097(22)03368-X","article-title":"An interesting case of myocarditis in a 60 year old male following administration of first dose of covid 19 MRNA vaccine","volume":"79","author":"Fichadiya","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2023.103340_bb0970","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/ijd.16113","article-title":"Alopecia areata following COVID -19 vaccination: vaccine-induced autoimmunity?","volume":"61","author":"May Lee","year":"2022","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2023.103340_bb0975","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12020-022-03118-4","article-title":"Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical management","volume":"78","author":"Caron","year":"2022","journal-title":"Endocrine"},{"key":"10.1016\/j.autrev.2023.103340_bb0980","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-244125","article-title":"Guillain-Barr\u00e9 syndrome after COVID-19 vaccination","volume":"14","author":"McKean","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.autrev.2023.103340_bb0985","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12026-020-09152-6","article-title":"Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine","volume":"68","author":"Kanduc","year":"2020","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2023.103340_bb0990","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1177\/0961203309345724","article-title":"Adjuvants and autoimmunity","volume":"18","author":"Israeli","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2023.103340_bb0995","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nrrheum.2009.196","article-title":"Vaccines and autoimmunity","volume":"5","author":"Agmon-Levin","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2023.103340_bb1000","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1126\/science.1135299","article-title":"Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling","volume":"314","author":"Gavin","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.autrev.2023.103340_bb1005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2013.10.004","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects","volume":"47","author":"Perricone","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2023.103340_bb1010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.06.012","article-title":"Bystander activation and autoimmunity","volume":"103","author":"Pacheco","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2023.103340_bb1015","first-page":"1","article-title":"The activation of bystander CD8+ T cells and their roles in viral infection","volume":"51","author":"Kim","year":"2019","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.autrev.2023.103340_bb1020","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1126\/science.272.5270.1947","article-title":"Induction of Bystander T cell proliferation by viruses and type I interferon in vivo","volume":"272","author":"Tough","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.autrev.2023.103340_bb1025","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/eji.201040466","article-title":"Bystander activation of CD4 + T cells: HIGHLIGHTS","volume":"40","author":"Boyman","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2023.103340_bb1030","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2230.2001.00852.x","article-title":"Epitope spreading: protection from pathogens, but propagation of autoimmunity?: Epitope spreading","volume":"26","author":"Powell","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2023.103340_bb1035","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.imlet.2014.11.001","article-title":"B cell epitope spreading: Mechanisms and contribution to autoimmune diseases","volume":"163","author":"Cornaby","year":"2015","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2023.103340_bb1040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/ar3433","article-title":"Mechanisms of B cell autoimmunity in SLE","volume":"13","author":"D\u00f6rner","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2023.103340_bb1045","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41591-022-01727-0","article-title":"Boosting immunity to Omicron","volume":"28","author":"Shen","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2023.103340_bb1050","doi-asserted-by":"crossref","first-page":"E58","DOI":"10.1503\/cmaj.1095982","article-title":"An early look at Omicron","volume":"194","author":"Vogel","year":"2022","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.autrev.2023.103340_bb1055","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-022-00996-y","article-title":"COVID-19 vaccine development: milestones, lessons and prospects","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct Target Ther"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223000745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223000745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:29:42Z","timestamp":1761600582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223000745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":207,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1568997223000745"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103340","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into new-onset autoimmune diseases after COVID-19 vaccination","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103340"}}